These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6028086)

  • 1. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
    Csányi E; Halász M
    Br J Cancer; 1967 Jun; 21(2):353-7. PubMed ID: 6028086
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaco-biochemical studies on cytotoxic polyol derivates. I. Effects of 1-6-dibromo-1-6-dideoxy-dulcitol on sensitive, resistant and refractor tumours.
    Vályi-Nagy T; Jeney A; Szabó J; Szabó I; Institoris L
    Eur J Cancer (1965); 1969 Sep; 5(4):403-14. PubMed ID: 5346869
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the carrying molecule in the cross-resistance against sugar alcohol derivatives.
    Gáti E; Horváth IP
    Eur J Cancer (1965); 1969 Dec; 5(6):553-7. PubMed ID: 5386716
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
    Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
    Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
    [No Abstract]   [Full Text] [Related]  

  • 5. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor effectiveness of improsulfan on nitrogen mustard-resistant Yoshida sarcoma cells.
    Okumoto T; Sugimoto N; Imamura H
    Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):3003-8. PubMed ID: 203408
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.
    Gerhartz HH; Liss E; Schmidt H
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):257-63. PubMed ID: 479265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on cross-resistance to degranol- and dibromodulcitol-resistant Yoshida tumours.
    Gáti E
    Int J Cancer; 1968 Mar; 3(2):260-4. PubMed ID: 5649161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in lysosomal enzyme activities of Yoshida sarcoma cells in rats treated with anticancer agents in relation to their therapeutic effects.
    Abe I; Sato S
    Sci Rep Res Inst Tohoku Univ Med; 1974 Dec; 21(3-4):76-86. PubMed ID: 4467316
    [No Abstract]   [Full Text] [Related]  

  • 14. [The cytotoxic effect of plasmin on yoshida sarcoma cells].
    Hiemeyer V; Hilgard P; Kottmann R
    Z Krebsforsch; 1969; 72(1):36-42. PubMed ID: 4183690
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiosensitizing action of ametohepazon on the irradiated tumor tissues. I. Combined therapy on Yoshida sarcoma.
    Tobe T; Niibe H; Koike N; Yonome I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Nov; 27(8):987-94. PubMed ID: 5245252
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 17. The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.
    Fox BW
    Int J Cancer; 1969 Jan; 4(1):54-60. PubMed ID: 5346476
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory activity of L-asparaginase from Mycobacterium tuberculosis on Yoshida ascites sarcoma in rats.
    Reddy VV; Jayaram HN; Sirsi M; Ramakrishnan T
    Arch Biochem Biophys; 1969 Jun; 132(1):262-7. PubMed ID: 4978855
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigations on the mechanism of action of cytotoxic hexitols. I. Cross-resistance investigations on Yoshida sarcoma tumour.
    Jeney A; Szabó J; Vályi-Nagy T
    Neoplasma; 1968; 15(3):231-5. PubMed ID: 5667085
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxic effects of snake venoms on KB and Yoshida sarcoma cells.
    Tu AT; Giltner JB
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):783-6. PubMed ID: 4456506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.